The Boston keratoprosthesis 2014: a step in the evolution of artificial corneas
详细信息 查看全文
- 作者：Claes H. Dohlman MD ; PhD (1)
Andrea Cruzat (1)
Michelle White (1)
1. Boston Keratoprosthesis Research and Development ; Massachusetts Eye and Ear Infirmary ; 243 Charles Street ; 02114 ; Boston ; MA ; USA - 关键词：Artificial cornea ; Keratoprosthesis ; K眉nstliche Hornhaut ; Keratoprothese
- 刊名：Spektrum der Augenheilkunde
- 出版年：2014
- 出版时间：December 2014
- 年：2014
- 卷：28
- 期：6
- 页码：226-233
- 全文大小：530 KB
- 参考文献：1. Akpek EK, Harissi-Dagher M, Petrarca R, Butrus SI, Pineda R II, Aquavella JV, Dohlman CH. Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study. Am J Ophthalmol. 2007;144:227鈥?1. CrossRef
2. Akpek EK, Aldave AJ, Aquavella JV. The use of precut, 纬-irradiated corneal lenticules in Boston type I keratoprosthesis implantation. Am J Ophthalmol. 2012;154:495鈥?. CrossRef
3. Al-Merjan J, Sadeq N, Dohlman CH. Temporary tissue coverage of keratoprosthesis. Middle East J Ophthalmol. 2000;8:12鈥?.
4. Ament JD, Spurr-Michaud SJ, Dohlman CH, Gipson IK. The Boston keratoprosthesis: comparing corneal epithelial cell compatibility with titanium and PMMA. Cornea. 2009;28:808鈥?1. CrossRef
5. Ament JD, Tilahun Y, Mudawi E, Pineda R. Role for ipsilateral autologous corneas as a carrier for the Boston keratoprosthesis: the Africa experience. Arch Ophthalmol. 2010a;128:795鈥?. CrossRef
6. Ament JD, Todani A, Pineda R, Shen TT, Aldave AJ, Dohlman CH, Chodosh J. Editorial: global corneal blindness and the Boston keratoprosthesis type I. Am J Ophthalmol. 2010b;149:537鈥?. CrossRef
7. Aquavella JV, Gearinger MD, Akpek EK, McCormick GJ. Pediatric keratoprosthesis. Ophthalmology. 2007;114:989鈥?4. CrossRef
8. Arafat SN, Robert M-C, Shukla AN, Dohlman CH, Chodosh J, Ciolino JB. UV cross-linking of donor corneas confers resistance to keratolysis. Cornea. 2014a;33:955鈥?. CrossRef
9. Arafat SN, Suelves AM, Spurr-Michaud S, Chodosh J, Foster CS, Dohlman CH, Gipson IK. Neutrophil collagenase, gelatinase, and myeloperoxidase in tears of patients with Stevens-Johnson syndrome and ocular cicatricial pemphigoid. Ophthalmology. 2014b;121:79鈥?7. CrossRef
10. Bath PE, McCord RC, Cox KC. Nd: YAG laser discission of retroprosthetic membrane: a preliminary report. Cornea. 1983;2:225鈥?.
11. Behlau I, Mukherjee K, Todani A, Tisdale AS, Cade F, Wang L, Leonard EM, Zakka FR, Gilmore MS, Jakobiec FA, Dohlman CH, Klibanov AM. Biocompatibility and biofilm inhibition of N, N-hexyl,methyl-polyethylenimine bonded to Boston keratoprosthesis materials. Biomaterials. 2011;32:8783鈥?6. CrossRef
12. Behlau I, Martin KV, Martin JN, Naumova EN, Cadorette JJ, Sforza JT, Pineda R II, Dohlman CH. Infectious endophthalmitis in Boston keratoprosthesis: incidence and prevention. Acta Ophthalmol. 2014;92:1鈥?0. CrossRef
13. Bersudsky V, Blum-Hareuveni T, Rehany U, Rumelt S. The profile of repeated corneal transplantation. Ophthalmology. 2001;108:461鈥?. CrossRef
14. Beyer J, Todani A, Dohlman C. Prevention of visually debilitating deposits on soft contact lenses in keratoprosthesis patients. Cornea. 2011;30:1419鈥?2. CrossRef
15. Boston Keratoprosthesis Bibliography. Boston Keratoprosthesis Newsletter 2013 and 2014. eyeandear.org/for-professionals/physician-resources/keratoprosthesis/" class="a-plus-plus">http://www.masseyeandear.org/for-professionals/physician-resources/keratoprosthesis/. Accessed: 1 Sept 2014.
16. Cade F, Grosskreutz CL, Tauber A, Dohlman CH. Glaucoma in eyes with severe chemical burn, before and after keratoprosthesis. Cornea. 2011;30:1322鈥?. CrossRef
17. Cade F, Paschalis EI, Regatieri CV, Vavvas DG, Dana R, Dohlman CH. Alkali burn to the eye: protection using TNF-伪 inhibition. Cornea. 2014;33:382鈥?. CrossRef
18. Cardona H. Keratoprosthesis; acrylic optical cylinder with supporting intralamellar plate. Am J Ophthalmol. 1962;54:284鈥?4. CrossRef
19. Cardona H, DeVoe AG. Prosthokeratoplasty. Trans Am Acad Ophthalmol Otolaryngol. 1977;83:271鈥?0.
20. Chang HP, Luo ZK, Chodosh J, Dohlman CH, Colby KA. Primary type I Boston keratoprosthesis in non-autoimmune corneal diseases. Submitted to Cornea; 2014.
21. Ciolino JB, Hoare TR, Iwata NG, Behlau I, Dohlman CH, Langer R, Kohane DS. A drug-eluting contact lens. Invest Ophthalmol Vis Sci. 2009;50:3346鈥?2. CrossRef
22. Cilolino JB, Belin MW, Todani A, Al-Arfaj K, Rudnisky CJ, Boston Keratoprosthesis Type 1 Study Group. Retention of the Boston keratoprosthesis type 1: multicenter study results. Ophthalmology. 2013;120:1195鈥?00. CrossRef
23. Crnej A, Omoto M, Dohlman TH, Graney JM, Dohlman CH, Drnovsek-Olup B, Dana R. A novel murine model for keratoprosthesis. Invest Ophthalmol Vis Sci. 2014a;55:3681鈥?. CrossRef
24. Crnej A, Paschalis EI, Salvador-Culla B, Tauber A, Drnovsek-Olup B, Shen LQ, Dohlman CH. Glaucoma progression and role of glaucoma surgery in patients with Boston keratoprosthesis. Cornea. 2014b;33:349鈥?4. CrossRef
25. Cruzat A, Shukla A, Dohlman CH, Colby K. Wound anatomy after type 1 Boston KPro using oversized back plates. Cornea. 2013a;32:1531鈥?. doi:10.1097/ICO.0b013e3182a854ac. CrossRef
26. Cruzat A, Tauber A, Shukla A, Paschalis EI, Pineda R, Dohlman CH. Low-cost and readily available tissue carriers for the Boston keratoprosthesis: a review of possibilities. J Ophthalmol. 2013b;2013:686587. CrossRef
27. Dohlman CH. Post operative regimen and repair of complications after keratoprosthesis surgery. Refract Corneal Surg. 1993;9:198.
28. Dohlman CH. Pellier de Quengsy and his keratoprosthesis. In: Mannis MJ, Mannis AA, editors. Corneal transplantation. Oostende: JP Wayenborgh; 1999. pp.聽52鈥?4.
29. Dohlman CH, Doane MG. Some factors influencing outcome after keratoprosthesis surgery. Cornea. 1994;13:214鈥?. CrossRef
30. Dohlman CH, Dohlman JG. Aqueous shunt to the ocular surface for severe dry eyes. Digit J Ophthalmol. 2005;11:2.
31. Dohlman CH, Webster RG, Biswas SK, Doane MG, Holmberg A. Collar-button prosthesis glued to a corneal graft. In: Polack FM, editor. Corneal and external diseases of the eye. Springfield: Charles C. Thomas, Springfield, Illinois; 1970. pp聽189鈥?2.
32. Dohlman CH, Dudenhoefer EJ, Khan BF, Dohlman JG. Corneal blindness from end-stage Sj枚gren鈥檚 syndrome and graft-versus-host disease. Adv Exp Med Biol. 2002a;506:1335鈥?. CrossRef
33. Dohlman CH, Dudenhoefer EJ, Khan BF, Morneault S. Protection of the ocular surface after keratoprosthesis surgery: the role of soft contact lenses. CLAO J. 2002b;28:72鈥?.
34. Dohlman CH, Harissi-Dagher M, Graney J. The Boston keratoprosthesis: a new threadless design. Digit J Ophthalmol. 2007;13:1鈥?.
35. Dohlman JG, Foster CS, Dohlman CH. Boston keratoprosthesis in Steven-Johnson syndrome: a case of using infliximab to prevent tissue necrosis. Digit J Ophthalmol. 2009;15:1鈥?.
36. Dohlman CH, Grosskreutz CL, Chen TC, Pasquale LR, Rubin PAD, Kim EC, Durand M. Shunts to divert aqueous humor to distant epithelialized cavities after keratoprosthesis surgery. J Glaucoma. 2010;19:111鈥?.
37. Donn A. Additional follow-up of 34 cases of prosthokeratoplasty. Trans Am Acad Ophthalmol Otolaryngol. 1977;83:281.
38. Durand ML, Dohlman CH. Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea. 2009;28:896鈥?01. CrossRef
39. Fadlallah A, Atallah M, Cherfan G, Awwad ST, Syed ZA, Melki SA. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting. Cornea. 2014;33:235鈥?.
40. Goldman DR, Hubschman J-P, Aldave AJ, Chiang A, Huang JS, Bourges J-L, Schwartz SD. Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis. Retina. 2013;33:532鈥?1. CrossRef
41. Grassi CM, Crnej A, Paschalis EI, Colby K, Dohlman CH, Chodosh J. Idiopathic vitritis in the setting of Boston keratoprosthesis. Submitted to Cornea; 2014.
42. Harissi-Dagher M, Khan BF, Schaumberg DA, Dohlman CH. Importance of nutrition to corneal grafts when used as a carrier of the Boston keratoprosthesis. Cornea. 2007;26:564鈥?. CrossRef
43. Harissi-Dagher M, Beyer J, Dohlman CH. The role of soft contact lenses as an adjunct to the Boston keratoprosthesis. Int Ophthalmol Clin. 2008;48:43鈥?1. CrossRef
44. Hicks CR, Crawford GJ, Tan DT, Snibson GR, Sutton GL, Downie N, Gondhowiardjo TD, Lam DS-C, Werner L, Apple D, Constable IJ. AlphaCor cases: comparative outcomes. Cornea. 2003;22:583鈥?0. CrossRef
45. Iakymenko S. Forty-five years of keratoprosthesis study and application at the Filatov Institute: a retrospective analysis of 1 060 cases. Int J Ophthalmol. 2013;6:375鈥?0.
46. Jardeleza MS, Rheaume M-A, Chodosh J, Lane AM, Dohlman CH, Young L. Retinal detachments after Boston keratoprosthesis: incidence, predisposing factors and visual outcomes. Submitted to Retina; 2014.
47. Kanellopoulos AJ, Asimellis G. Long-term safety and efficacy of high-fluence collagen crosslinking of the vehicle cornea in Boston keratoprosthesis type 1. Cornea. 2014;33:914鈥?. CrossRef
48. Khan BF, Harissi-Dagher M, Pavan-Langston D, Aquavella JV, Dohlman CH. The Boston keratoprosthesis in herpetic keratitis. Arch Ophthalmol. 2007;125:745鈥?. CrossRef
49. Lass JH, Campbell RC, Rose J, Foster CS, Dohlman CH. Medroxyprogesterone on corneal ulceration. Its effects after alkali burns on rabbits. Arch Ophthalmol. 1981;99:673鈥?. CrossRef
50. Lekhanont K, Thaweesit P, Muntham D, Chuckpaiwong V, Vongthongsri A. Medium-term outcomes of Boston type 1 keratoprosthesis implantation in Bangkok, Thailand. Cornea. 2014;33:1312鈥?. CrossRef
51. Linnola RJ, Happonen RP, Andersson OH, Vedel E, Yli-Urpo AU, Krause U, Laatikainen L. Titanium and bioactive glass-ceramic coated titanium as materials for keratoprosthesis. Exp Eye Res. 1996;63:471鈥?. CrossRef
52. Ma JJ, Graney JM, Dohlman CH. Repeat penetrating keratoplasty versus the Boston keratoprosthesis in graft failure. Int Ophthalmol Clin. 2005;45:49鈥?9. CrossRef
53. Mannis MJ, Dohlman CH. The artificial cornea: a brief history. In: Mannis MJ, Mannis AA, editors. Corneal transplantation. A history in profiles. Oostende: JP Wayenborg; 1999. pp聽321鈥?5.
54. Melki S, Todani A, Cherfan G. An implantable intraocular pressure transducer: initial safety outcomes. JAMA Ophthalmol. 2014;132:1221鈥?. CrossRef
55. Moroz ZI. Artificial cornea. In: Fyodorov SN, editor. Microsurgery of the eye: main aspects. Moscow: MIR; 1987. p.聽27.
56. Netland PA, Terada H, Dohlman CH. Glaucoma associated with keratoprosthesis. Ophthalmology. 1998;105:751鈥?. CrossRef
57. Nouri M, Terada H, Alfonso EC, Foster CS, Durand ML, Dohlman CH. Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol. 2001;119:484鈥?. CrossRef
58. Nouri M, Durand ML, Dohlman CH. Sudden reversible vitritis after keratoprosthesis: an immune phenomenon? Cornea. 2005;24:915鈥?. CrossRef
59. Palioura S, Kim B, Dohlman CH, Chodosh J. The Boston keratoprosthesis type I in mucous membrane pemphigoid. Cornea. 2013;32:956鈥?1. CrossRef
60. Paschalis EI, Chodosh J, Sperling RA, Salvador-Culla B, Dohlman C. A novel implantable glaucoma valve using ferrofluid. PLoS One. 2013a;8:e67404. CrossRef
61. Paschalis EI, Chodosh J, Spurr-Michaud S, Cruzat A, Tauber A, Behlau I, Gipson I, Dohlman CH. In vitro and in vivo assessment of titanium surface modification for coloring the backplate of the Boston keratoprosthesis. Invest Ophthalmol Vis Sci. 2013b;54:3863鈥?3. CrossRef
62. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012;96:614鈥?. doi:10.1136/bjophthalmol-2011-300539. CrossRef
63. Pavan-Langston D, Dohlman C. Boston keratoprosthesis treatment of Herpes zoster neurotrophic keratopathy. Ophthalmology. 2008;115:S21鈥?. CrossRef
64. Rao GN, Blatt HL, Aquavella JV. Results of keratoprosthesis. Am J Ophthalmol. 1979;88:190鈥?04. CrossRef
65. Ray S, Khan BF, Dohlman CH, D鈥橝mico DJ. Management of vitreoretinal complications in eyes with permanent keratoprosthesis. Arch Ophthalmol. 2002;120:559鈥?6. CrossRef
66. Rivier D, Paula JS, Kim E, Dohlman CH, Grosskreutz CL. Glaucoma and keratoprosthesis surgery: role of adjunctive cyclophotocoagulation. J Glaucoma. 2009;18:321鈥?. CrossRef
67. Robert M-C, Biernacki K, Harissi-Dagher M. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers. Cornea. 2012;31:339鈥?5. CrossRef
68. Robert M-C, Pomerleau V, Harissi-Dagher M. Complications associated with Boston keratoprosthesis type 1 and glaucoma drainage devices. Br J Ophthalmol. 2013;97:573鈥?. CrossRef
69. Robert MC, Arafat SN, Ciolino JB. Collagen crosslinking of the Boston keratoprosthesis donor carrier to prevent corneal melting in high-risk patients. Eye Contact Lens. 2014a;40:376鈥?1. CrossRef
70. Robert MC, Spurr-Michaud S, Frenette M, Young D, Gipson IK, Dohlman CH. Stability and in vitro toxicity of an infliximab eye drop formulation. J Pharma Comp. 2014b;18:418鈥?6.
71. Salvador-Culla B, Behlau I, Sayegh RR, Stacy RC, Dohlman CH, Delori F. Very low risk of light-induced retinal damage during Boston keratoprosthesis surgery: a rabbit study. Cornea. 2014a;33:184鈥?0. CrossRef
72. Salvador-Culla B, Jeong KJ, Kolovou PE, Chiang HH, Chodosh J, Langer R, Dohlman CH, Kohane DS. Titanium coating of the Boston keratoprosthesis. Submitted to Biomaterials; 2014b.
73. Sa-ngiampornpanit T, Thiagalingam S, Dohlman CH. Boston keratoprosthesis in epithelial downgrowth. Digit J Ophthalmol. 2009;15:1鈥?.
74. Sayegh RR, Dohlman CH. Wide-angle fundus imaging through the Boston keratoprosthesis. Retina. 2013;33:1188鈥?2. CrossRef
75. Sayegh RR, Ang LPK, Foster CS, Dohlman CH. The Boston keratoprosthesis in Stevens-Johnson syndrome. Am J Ophthalmol. 2008;145:438鈥?4. CrossRef
76. Sayegh RR, Avena Diaz L, Vargas-Martin F, Webb RH, Dohlman CH, Peli E. Optical functional properties of the Boston keratoprosthesis. Invest Ophthalmol Vis Sci. 2010;51:857鈥?3. CrossRef
77. Stone W, Herbert E. Experimental study of plastic material as replacement for the cornea; a preliminary report. Am J Ophthalmol. 1953;36:168鈥?3. CrossRef
78. Todani A, Behlau I, Fava MA, Cade F, Cherfan DG, Zakka FR, Jakobiec FA, Gao Y, Dohlman CH, Melki SA. Intraocular pressure measurement by radio wave telemetry. Invest Ophthalmol Vis Sci. 2011a;52:9573鈥?0. CrossRef
79. Todani A, Ciolino JB, Ament JD, Colby KA, Pineda R, Belin MW, Aquavella JV, Chodosh J, Dohlman CH. Titanium back plate for a PMMA keratoprosthesis: clinical outcomes. Graefes Arch Clin Exp Ophthalmol. 2011b;249:1515鈥?. CrossRef
80. White ML, Chodosh J, Jisung J, Dohlman CH. Incidence of ocular burns (thermal, chemical) and SJS spectrum: relevance for keratoprosthesis surgery. To be submitted; 2014.
81. World Health Organization. Visual impairment and blindness. Fact Sheet No. 282. 2014;93:563鈥?. (Accessed on 23 Sept).
82. Yaghouti F, Nouri M, Abad JC, Power WJ, Doane MG, Dohlman CH. Keratoprosthesis: preoperative prognostic categories. Cornea. 2001;20:19鈥?3. CrossRef - 刊物主题：Ophthalmology;
- 出版者：Springer Vienna
- ISSN：1613-7523
文摘